摘要 : Purpose: To examine outcomes of r/r DLBCL Methods: Retrospective study using COTA EHR database (2014 early 2020) Results: Majority of patients received pharmacological treatment in 3L and 4L; median OS times were 7.7 and 4.4 month... 展开
作者 | Hamadani~ Mehdi Liao~ Laura Yang~ Tony Chen~ Lei Moskowitz~ Craig |
---|---|
作者单位 | |
期刊名称 | 《Clinical lymphoma, myeloma & leukemia》 |
总页数 | 9 |
语种/中图分类号 | 英语 / R73 |
关键词 | Overall survival Response rates Chemotherapy or chemoimmunotherapy (CT/CIT) Targeted therapy (TT) Chimeric antigen receptor T cells (CAR-T) DLBCL PATIENTS CHEMOTHERAPY |
馆藏号 | N2010EPST0000770 |